EBNA1 Inhibitors Block Proliferation of Spontaneous Lymphoblastoid Cell Lines From Patients With Multiple Sclerosis and Healthy Controls.
Maria Chiara G MonacoSamantha S SoldanChenhe SuAnnaliese ClauzeJohn F CooperRishi J PatelFang LuRandall J HughesTroy E MessickFrances C AndradaJoan OhayonPaul M LiebermanSteven JacobsonPublished in: Neurology(R) neuroimmunology & neuroinflammation (2023)
B cells in MS and suggests that a clinical trial testing the effect of EBNA1 inhibitors in MS may be warranted.